Samplix raises $27M Series B
Samplix: Samplix develops droplet microfluidics technology for functional single-cell analysis.
- Round
- Series B
- Amount
- $27M (€25M)
- Announced
- Lead investors
- WLanholding GmbH
- Headquarters
- Denmark
Source (found by the agent, not yet verified)
More: Samplix funding history · rounds in October 2026 · rounds in Denmark